Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

High Pregnancy Rates with Single Embryo Transfer

Fertil Steril; ePub 2017 Sep 16; Mersereau, et al

A 10%-15% reduction in live birth rate and a 47% decrement in multiple birth rate with single embryo transfer (SET) compared with double embryo transfer (DET) was observed in the setting of favorable patient prognostic factors, a recent study found. This retrospective cohort analyzed factors associated with high live birth rate and low multiple birth rate in fresh and frozen-thawed assisted reproductive technology (ART) cycles between 2004 and 2013. The study population included 181,523 women undergoing in vitro fertilization (IVF) with autologous fresh first cycles, 27,033 with fresh first oocyte donor cycles, 37,658 with fresh second cycles, and 35,446 with frozen-thawed second cycles. Researchers found:

  • In patients with favorable prognostic factors, including younger maternal age, transfer of a blastocyst, and additional embryos cryopreserved, the gain in the live birth rate from SET to DET was ~10% to 15%.
  • However, the multiple birth rate increased from ~2% to >49% in both autologous and donor fresh and frozen-thawed transfer cycles.


Mersereau J, Stanhiser J, Coddington C, Jones T, Luke B, Brown MB. Patient and cycle characteristics predicting high pregnancy rates with single embryo transfer: An analysis of the Society for Assisted Reproductive Technology outcomes between 2004 and 2013. [Published online ahead of print September 16, 2017]. Fertil Steril. doi:10.1016/j.fertnstert.2017.07.1167.

This Week's Must Reads

Prophylactic Antibiotic Use in Labor & Delivery, Obstet Gynecol; 2018 Sep; Coleman, et al

USPSTF on Screening for Cervical Cancer, JAMA; 2018 Aug 21; US Preventive Services Task Force

Prevention of Obstetric Lacerations at Vaginal Delivery, Obstet Gynecol; 2018 Sep; Cichowski, et al

Effect of Menstrual Bleeding on IUD Discontinuation, Am J Obstet Gynecol; ePub 2018 Aug 28; Hobby, et al

Leukemia risk after maternal contraception use, Hargreave M et al. Lancet Oncol. 2018 Sep 6. doi: 10.1016/S1470-2045(18)30479-0

Must Reads in Reproductive Endocrinology

Leukemia risk after maternal contraception use, Hargreave M et al. Lancet Oncol. 2018 Sep 6. doi: 10.1016/S1470-2045(18)30479-0

Treatment Update for Polycystic Ovary Syndrome, Obstet Gynecol; ePub 2018 Jun; Legro, et al

Fertility Awareness Based Contraceptive Methods, Contraception; ePub 2018 Apr 25; Polis, et al

Depression Among Women of Childbearing Age, Obstet Gynecol; ePub 2018 Mar 8; Guo, et al

Marijuana Use and Time to Pregnancy, Fertil Steril; ePub 2018 Mar 16; Kasman, et al